Clinical Trials Education Center
ANNOUNCEMENTS
ZEPHYRUS Phase 3 clinical study of pamrevlumab in patients with IPF is now recruiting.
ISABELA Phase 3 clinical study of GLPG1690 in patients with IPF is now recruiting.
The PFF does not promote or represent that any investigational new drugs mentioned are safe or effective. The information provided is for general information only and is not intended as medical or other professional advice. It should not be relied upon as a substitution for consultation with qualified professionals who are familiar with your individual needs. PFF does not recommend any commercial product or services. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators